<DOC>
	<DOC>NCT00476606</DOC>
	<brief_summary>To evaluate clinical and immunological outcome of children treated with HAART.</brief_summary>
	<brief_title>A Prospective Cohort of Children With HIV Infection</brief_title>
	<detailed_description>This is a long term cohort study that was started in 2002. Currently, there are 120 children enrolled in the study and are receiving HIV care according to standard practice set by the Thai Ministry of Public Health. HIV-infected parents also receive care at the same clinic.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Children who are part of the ATC program at Chulalongkorn hospital and at HIVNAT, The Thai Red Cross AIDS research center Children who fulfil criteria to start HAART according to the ATC program Children who are switched to second regimen or salvage therapy Children who are on any antiretroviral regimens, including post trial children from other HIVNAT study (both at HIVNAT and Khon Kaen University sites) Children with HIV infection who are not on antiretroviral therapy Caretakers understand the purpose of data and plasma samples collection, and have signed the consent form Patients and caretakers may choose to stop HAART at anytime during the study. If they agree, we would continue to follow them in this study.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV children</keyword>
	<keyword>HAART</keyword>
	<keyword>ARV</keyword>
	<keyword>Second line HAART</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Combination drug</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>